Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Intervalo de año de publicación
1.
Tohoku J Exp Med ; 255(2): 111-121, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34629365

RESUMEN

Gastric cancer is the one of the most lethal malignancies of digestive system. Identifying molecular biomarkers is invaluable in help predicting clinical outcomes and developing targeted chemotherapies. GINS complex subunit 2 (GINS2) plays an essential role in the initiation and elongation of DNA replication. Although there have been studies revealing the prognostic significance of GINS2 in breast cancer and lung cancer, its involvement and function in gastric cancer need to be elucidated. We retrospectively enrolled a cohort of gastric adenocarcinoma patients after surgical resection (n = 123). By analyzing the mRNA and protein levels of GINS2 in tissue samples, we found that GINS2 presented a higher expression in tumor tissues than in adjacent normal stomach tissues. Besides, GINS2 level was positively correlated with tumor size and gastric adenocarcinoma tumor stage, implying its potential role as a tumor promoter. Univariate and multivariate analyses identified that patients with lower GINS2 showed a better overall survival compared to those with higher GINS2 expression. In addition, cellular and xenograft experiments confirmed the role of GINS2 in facilitating tumor proliferation both in vitro and in vivo. To our knowledge, this is the initial finding on GINS2 in promoting gastric adenocarcinoma progression. In conclusion, our study revealed a pro-oncogenic role of GINS2 in gastric cancer.


Asunto(s)
Adenocarcinoma , Neoplasias Gástricas , Adenocarcinoma/genética , Biomarcadores de Tumor/genética , Proliferación Celular , Proteínas Cromosómicas no Histona/genética , Proteínas Cromosómicas no Histona/metabolismo , Regulación Neoplásica de la Expresión Génica , Humanos , Pronóstico , Estudios Retrospectivos , Neoplasias Gástricas/genética
2.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-887416

RESUMEN

@#[摘 要] 目的:探究微小RNA-504(miRNA-504)在胃癌(GC)组织中的表达水平及其对GC细胞生物学行为的调控机制。方法:收集2020年6月至2020年12月期间三亚中心医院外科收治的48例胃癌患者的肿瘤组织及癌旁组织标本,qPCR检测组织中miR-504、肿瘤蛋白53诱导型核蛋白1(tumor protein 53-induced nuclear protein 1,TP53INP1)mRNA的水平,WB法检测TP53INP1水平。体外培养人胃癌细胞BGC-823,分为对照组(正常培养的BGC-823细胞)、miR-504 mimic组、mimic-NC组、miR-504 inhibitor组、inhibitor-NC组、miR-504 inhibitor+si-NC组、miR-504 inhibitor+si-TP53INP1组,qPCR检测细胞中miR-504和TP53INP1 mRNA的表达,MTT法、流式细胞术、划痕实验和Transwell侵袭实验分别检测各组细胞的增殖、凋亡、迁移和侵袭能力,WB法检测各组细胞中增殖、迁移和侵袭相关蛋白(Cyclin D1、E-cadherin、MMP-2、MMP-9)以及TP53INP1的表达。双荧光素酶报告基因实验进一步验证miR-504与TP53INP1 mRNA的靶向关系。结果:与癌旁组织相比,胃癌组织中miR-504的表达显著升高(P<0.05),而TP53INP1 mRNA和蛋白表达水平显著降低(P<0.05或P<0.01),miR-504和TP53INP mRNA两者的表达呈负相关(P<0.01)。与对照组相比,miR-504 mimic组BGC-823细胞中miR-504的表达显著升高(P<0.05)、TP53INP1 mRNA和蛋白的表达显著降低(均P<0.05),且细胞增殖率、划痕愈合率、侵袭入Transwell小室下层的细胞数量,Cyclin D1、MMP-2、MMP-9蛋白表达均显著增加,细胞凋亡率和E-cadherin蛋白表达均显著降低(均P<0.05)。转染miR-504 inhibitor能显著下调BGC-823中miR-504的表达、上调TP53INP1 mRNA和蛋白的表达,抑制细胞的增殖、迁移与侵袭能力而促进细胞凋亡(均P<0.05);而下调TP53INP1的表达可明显减弱miR-504下调对BGC-823细胞增殖、迁移与侵袭的抑制作用(P<0.01)。miR-504高表达能明显抑制野生型TP53INP1质粒的荧光素酶活性(P<0.05)。结论:miR-504在胃癌组织中呈高表达,下调miR-504可抑制胃癌BGC-823细胞的恶性生物学行为而促进其凋亡,其作用机制可能与靶向调控TP53INP1的表达有关。

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...